International Medical Device Regulators Forum (IMDRF)

What is the IMDRF?

The International Medical Device Regulators Forum, or IMDRF, is a voluntary group of medical device regulators working to accelerate regulatory harmonization and convergence. It is not a global regulator and does not approve products.

IMDRF was established in 2011 to build on the work of the Global Harmonization Task Force, or GHTF. The official About IMDRF page describes its members, observers and affiliate structure.

Which regulators participate in IMDRF?

Current member jurisdictions include Australia, Brazil, Canada, China, the European Union, Japan, Russia, Singapore, South Korea, Switzerland, the United Kingdom and the United States. Argentina, the World Health Organization and Saudi Arabia are official observers, and regulators from many additional countries participate as affiliates.

Membership status can change, so an evergreen glossary page should link to the official list instead of presenting participation as permanent. Pure Global has market guidance for many participating jurisdictions through its Markets hub.

What does IMDRF produce?

IMDRF working groups develop technical and procedural documents on subjects such as adverse-event terminology, unique device identification, software, cybersecurity, personalized medical devices, clinical evaluation and regulatory review practices. Its Strategic Plan 2026–2030 describes the Forum’s current priorities.

These documents provide common concepts that regulators can use when developing or aligning national systems. They also give manufacturers a useful reference point when building evidence and data structures intended for several markets.

Are IMDRF documents legally binding?

Not by themselves. IMDRF is a forum rather than a legislature or regulatory authority. An IMDRF document becomes legally relevant when a jurisdiction incorporates, references or implements it through its own laws, regulations or guidance.

Manufacturers should therefore distinguish between an international recommendation and a market-specific legal requirement. A common IMDRF concept can be implemented differently by the FDA, European Commission, Health Canada or another authority.

How does IMDRF affect medical device manufacturers?

IMDRF work can reduce avoidable differences in submissions and post-market data, but it does not create a single worldwide approval. Manufacturers can use common terminology and evidence structures while still mapping them to each target jurisdiction.

Related Pure Global resources include our regulator guides for the US FDA, China NMPA, Japan PMDA, Singapore HSA and Swissmedic.